CRISPR/Cas9 endonuclease-mediated genome editing is used to insert a 9 amino acid (YPYDVPDYA) hemagluttin (HA) tag in N-terminus. In addition, the insertion included three silent point mutation located in the PAM site to eliminate recleavage. (J:292643)